Aytu BioScience to Execute Reverse Stock Split in Anticipation of Uplisting its Common Stock to a National Exchange

Company Announces 1:12 Reverse Stock Split ENGLEWOOD, Colo., June 22, 2016, AYTU, /PRNewswire/ Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced today a one-for-twelve (1:12) reverse split of its issued and outstanding common stock. The reverse stock split will become effective after the market close on June 30, 2016 for holders of record on that date. Aytu s common stock will continue to trade on the The post Aytu BioScience to Execute Reverse Stock Split in Anticipation of Uplisting its Common Stock to a National Exchange appeared first on Public Wire.
http://bit.ly/28NlBc6

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: